Abstract
BackgroundVisual acuity is commonly used as a functional outcome measure in patients with age-related macular degeneration (AMD), despite having a weak correlation with self-perceived visual quality of life. Microperimetry is a useful method of detecting loss of macular function. We wanted to investigate the relationship between these two objective visual outcome measures and subjective vision-related quality of life, finding out which objective measure is more patient-relevant.MethodsFifty-one consecutive patients with AMD were recruited to the study. Participants were required to complete the Visual Function Questionnaire 39, the Early Treatment Diabetic Retinopathy Study visual acuity examination and a microperimetry assessment using the Micro Perimeter 3. One patient withdrew consent and seven patients dropped out due to cooperation difficulties under microperimetry. Forty-three patients with AMD were included in the study: twenty-eight patients with late AMD (exudative AMD) and fifteen patients with early (non-exudative) AMD. The right eye was included as standard, as was the eye with the best-corrected visual acuity.ResultsThere was a higher correlation between vision-related quality of life and macular sensitivity (r = 0.458; p = 0.014) than between vision-related quality of life and visual acuity (r = 0.446; p = 0.018) in patients with late AMD. There was a positive correlation between vision-related quality of life and macular sensitivity in patients with early AMD (r = 0.542; p = 0.037) while the correlation between vision-related quality of life and visual acuity in these patients was not statistically significant. Composite score (r = 0.469; p = 0.012) correlated highest with the nasal outer macular sub-region and near-distance activities score (r = 0.652; p < 0.001) correlated highest with the nasal inner macular sub-region in patients with late AMD. Correlations between composite score and macular sub-regions in patients with early AMD were not significant, but near-distance activities score correlated with the nasal outer macular sub-region in these patients (r = 0.469; p = 0.012).ConclusionsMacular sensitivity as measured using microperimetry correlates with vision-related quality of life in early AMD and in late AMD, showing it to be a patient-relevant outcome measure. Furthermore, the nasal sub-regions of the macula appear to be preferred retinal loci in patients with AMD.(338 words)
Highlights
Visual acuity is commonly used as a functional outcome measure in patients with age-related macular degeneration (AMD), despite having a weak correlation with self-perceived visual quality of life
Macular sensitivity as measured using microperimetry correlates with vision-related quality of life in early AMD and in late AMD, showing it to be a patient-relevant outcome measure
With regards the main aim of this study, there was a positive correlation between Visual Function Questionnaire (VFQ) composite score and bestcorrected visual acuity (BCVA) in patients with late AMD (r = 0.446; p = 0.018 Pearson’s Correlation), but the correlation between VFQ composite score and overall macular sensitivity in these patients was higher (r = 0.458; p = 0.014). (Fig. 2) There was a positive correlation between VFQ composite score and overall macular sensitivity in patients with early AMD (r = 0.542; p = 0.037) but the correlation between BCVA and VFQ composite score was not statistically significant
Summary
Visual acuity is commonly used as a functional outcome measure in patients with age-related macular degeneration (AMD), despite having a weak correlation with self-perceived visual quality of life. We wanted to investigate the relationship between these two objective visual outcome measures and subjective vision-related quality of life, finding out which objective measure is more patient-relevant. Outcome measures that are more patientrelevant are being sought after in clinical trials, but since patient relevance can be difficult to quantify, it is important to identify the objective measure of visual function most closely aligned with subjective experience. We wanted to investigate the relationship between vision-related quality of life measured using VFQ and objective measures of visual function, namely, visual acuity and microperimetry. The first study of its kind, our primary aim was to find the objective measure that is most patientrelevant in patients with AMD
Published Version (
Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have